SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that new and updated data from its lentiviral vector (LVV) gene addition programs in patients with sickle cell ...
Cabaletta Bio, Inc. has announced its participation in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2025, at 11:05 a.m. ET in New York City. The biotechnology company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results